Sensus Healthcare (SRTS) Capital Expenditures Growth (1y) (2018 - 2026)
Sensus Healthcare (SRTS) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -47.73% |
| 10 | Sensus Healthcare | 49.55 Mn | 31.23 Mn | - | -1,157.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,157.14% |
| Dec 31, 2025 | -136.33% |
| Sep 30, 2025 | 303.08% |
| Jun 30, 2025 | 107.07% |
| Mar 31, 2025 | -97.00% |
| Dec 31, 2024 | 490.36% |
| Sep 30, 2024 | -690.91% |
| Jun 30, 2024 | -274.43% |
| Mar 31, 2024 | 23,400.00% |
| Dec 31, 2023 | -69.03% |
| Sep 30, 2023 | -81.67% |
| Jun 30, 2023 | 386.67% |
| Mar 31, 2023 | -102.27% |
| Dec 31, 2022 | 605.26% |
| Sep 30, 2022 | 1,900.00% |
| Jun 30, 2022 | 542.86% |
| Mar 31, 2022 | -45.00% |
| Dec 31, 2021 | -63.46% |
| Sep 30, 2021 | -97.17% |
| Jun 30, 2021 | -50.00% |